BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38453820)

  • 1. ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.
    Meng W; Lu X; Wang G; Xiao Q; Gao J
    Funct Integr Genomics; 2024 Mar; 24(2):53. PubMed ID: 38453820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
    Li X; Jiang F; Ge Z; Chen B; Yu J; Xin M; Wang J; An L; Wei J; Wu L
    Dig Dis Sci; 2019 Nov; 64(11):3215-3227. PubMed ID: 31041640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
    Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
    Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
    Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
    Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor role of a newly discovered α-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase A.
    Wang J; Li Z; Yang X; Qiao Y; Feng C; Yu S; Jing H; Liu W; Ren L; Duan Q; Li XQ; Cao W
    Carbohydr Polym; 2021 Mar; 255():117532. PubMed ID: 33436261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
    Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-122-5p Inhibits the Proliferation, Invasion and Growth of Bile Duct Carcinoma Cells by Targeting ALDOA.
    Xu Z; Liu G; Zhang M; Zhang Z; Jia Y; Peng L; Zhu Y; Hu J; Huang R; Sun X
    Cell Physiol Biochem; 2018; 48(6):2596-2606. PubMed ID: 30121648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
    Shang R; Pu M; Li Y; Wang D
    Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacuolar protein sorting-associated protein 72 homolog (VPS72) binding to lysine acetyltransferase 5 (KAT5) promotes the proliferation, invasion and migration of hepatocellular carcinoma through regulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway.
    Chen T; Tu Y; Lv D; Lin K; Tang H; Huang W
    Bioengineered; 2022 Apr; 13(4):9197-9210. PubMed ID: 35383533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
    Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
    Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
    Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
    Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
    Liu R; Gou D; Xiang J; Pan X; Gao Q; Zhou P; Liu Y; Hu J; Wang K; Tang N
    Oncogene; 2021 Dec; 40(50):6707-6719. PubMed ID: 34650217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRD8, which is negatively regulated by miR-876-3p, promotes the proliferation and apoptosis resistance of hepatocellular carcinoma cells via KAT5.
    Yu Z; Chen T; Mo H; Guo C; Liu Q
    Arch Biochem Biophys; 2020 Oct; 693():108550. PubMed ID: 32860757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.
    Lei S; Yang J; Chen C; Sun J; Yang L; Tang H; Yang T; Chen A; Zhao H; Li Y; Du X
    J Exp Clin Cancer Res; 2016 May; 35():79. PubMed ID: 27178057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
    Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
    J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
    Liu W; Yin C; Liu Y
    Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066
    [No Abstract]   [Full Text] [Related]  

  • 20. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.